Does USTEKINUMAB Cause Gastrointestinal inflammation? 141 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Gastrointestinal inflammation have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
141
Reports of Gastrointestinal inflammation with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
0
Deaths
53
Hospitalizations
How Dangerous Is Gastrointestinal inflammation From USTEKINUMAB?
Of the 141 reports, 53 (37.6%) required hospitalization.
Is Gastrointestinal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Gastrointestinal inflammation?
ADALIMUMAB (2,170)
VEDOLIZUMAB (530)
INFLIXIMAB (441)
METHOTREXATE (218)
RISANKIZUMAB-RZAA (157)
PREDNISONE (121)
CAPECITABINE (94)
INFLIXIMAB-DYYB (92)
HUMIRA (91)
RITUXIMAB (90)
Which USTEKINUMAB Alternatives Have Lower Gastrointestinal inflammation Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE